New evidence regarding hormone replacement therapies is urgently required: Transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits

This publication has 85 references indexed in Scilit:

• Breast cancer risk in relation to different types of hormone replacement therapy in the E3N‐EPIC cohort
  International Journal of Cancer, 2004
• Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy
  JAMA, 2004
• Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS)
  American Heart Journal, 2003
• Breast cancer and hormone-replacement therapy in the Million Women Study
  The Lancet, 2003
• Effect of Oral and Transdermal Estrogen Replacement Therapy on Hemostatic Variables Associated With Venous Thrombosis
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2003
• Breast cancer and specific types of oral contraceptives: A large Norwegian cohort study
  International Journal of Cancer, 2003
• Hormones for coronary disease—full circle
  The Lancet, 2002
• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
  JAMA, 1998
• Comparison of the in vitro conversion of estradiol-17β to estrone of normal and neoplastic human breast tissue
  Molecular and Cellular Endocrinology, 1977